Cerebellar ataxia - Ataxia UK

Cerebellar ataxia

The Sheffield Ataxia Centre experience on the use of 3,4-diaminopyridine in SCA27B 

Cerebellar ataxia, Research News, SCAs /

The team at the Sheffield Ataxia Centre has recently published a paper in the Journal of Neurology. To read the paper please click here.  The paper details the Sheffield Ataxia Centre experience and gives some support to the potential use of 3,4-diaminopyridine as a therapy to alleviate symptoms […]

The Sheffield Ataxia Centre experience on the use of 3,4-diaminopyridine in SCA27B  Read More »

VICO Therapeutics Clinical Trial updates

Cerebellar ataxia, Cerebellar ataxia pharma news, Research News, SCAs /

Spinocerebellar ataxias (SCAs) are a group of rare, progressive hereditary genetic disorders that affects the cerebellum, brain stem and spinal cord. Currently, more than 30 types of SCAs have been identified. SCAs are caused by genetic mutations, which lead to faulty

VICO Therapeutics Clinical Trial updates Read More »

New paper published on the SARAhome scale to remotely assess ataxia symptoms in SCA3

Cerebellar ataxia, Research News, research project, SCAs /

In 2021, Ataxia UK co-funded a research project with the National Ataxia Foundation, ‘Assessment of ataxia severity under real-life conditions with SARAhome: A multicenter study in spinocerebellar ataxia type 3 (SCA3)’. This project was led by Dr

New paper published on the SARAhome scale to remotely assess ataxia symptoms in SCA3 Read More »

The Sheffield Ataxia Centre’s 2025 ataxia study day for healthcare professionals

Cerebellar ataxia, Research News /

Last month, on 7th November, the Ataxia UK-accredited Sheffield Ataxia Centre hosted an ataxia study day for healthcare professionals at the University of Sheffield, chaired by Consultant Neurologists Professor Marios Hadjivassiliou and Dr Priya Shanmugarajah, and organised

The Sheffield Ataxia Centre’s 2025 ataxia study day for healthcare professionals Read More »

New paper published on TG6 antibodies and patient outcomes in Gluten-related neurological disorders

Cerebellar ataxia, Research News /

Gluten-related disorders, also known as gluten sensitivity disorders, happen when a person’s immune system reacts to gluten, and immune cells called autoantibodies, mistakenly attack the body’s tissues. This is called an autoimmune response. There are numerous autoantibodies that can be

New paper published on TG6 antibodies and patient outcomes in Gluten-related neurological disorders Read More »

New study published on goal-directed Rehabilitation vs. Standard Care in those with hereditary Cerebellar ataxia

Cerebellar ataxia, Friedreich's ataxia, Research News, SCAs, spastic ataxias /

A study led by Dr Sarah Milne at the Murdoch Children’s Research Institute, Australia, has recently been published in the journal ANNALS of Neurology. The study looked at the impact

New study published on goal-directed Rehabilitation vs. Standard Care in those with hereditary Cerebellar ataxia Read More »

Ataxia UK hosts webinar on managing ataxia symptoms, presented by Dr. Michael Parkinson of the London Ataxia Centre

Cerebellar ataxia, DRPLA, Friedreich's ataxia, Research News, SCAs, spastic ataxias /

On Wednesday 5th February, Ataxia UK hosted a webinar and Q&A as part of Wellbeing Week, a week from 3rd – 7th February dedicated to providing support and information to

Ataxia UK hosts webinar on managing ataxia symptoms, presented by Dr. Michael Parkinson of the London Ataxia Centre Read More »

Cart
Checkout - £0.00
  • 0
  • 1
Scroll to Top